Wed, November 11, 2015
Tue, November 10, 2015
Mon, November 9, 2015
Fri, November 6, 2015
Thu, November 5, 2015
Wed, November 4, 2015
Tue, November 3, 2015
Mon, November 2, 2015

Christopher Raymond Upgraded (BIIB) to Buy on, Nov 5th, 2015

Christopher Raymond of Piper Sandler, Upgraded "Biogen Inc." (BIIB) to Buy on, Nov 5th, 2015.

Christopher has made no other calls on BIIB in the last 4 months.



There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 1 agrees with Christopher's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Brian Skorney of "Baird" Downgraded from Buy to Hold and Decreased Target to $316 on, Monday, July 27th, 2015


These are the ratings of the 4 analyists that currently disagree with Christopher


  • Geoffrey Porges of "Leerink Swann" Maintained at Buy with Decreased Target to $425 on, Tuesday, September 15th, 2015
  • Andrew Fein of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $380 on, Tuesday, August 11th, 2015
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $426 on, Monday, July 27th, 2015
  • Aaron Gal of "Bernstein" Upgraded from Hold to Buy and Decreased Target to $385 on, Monday, July 27th, 2015